The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus–associated neurological disease: From mechanism to treatment

References

• Amedee A M, Lacour N, Gierman J L, Martin L N, Clements J E, Bohn R, Harrison R M, Murphey-Corb M. Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol 1995; 69: 7982–7990
   Google Scholar
• An S F, Groves M, Gray F, Scaravilli F. Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol 1999; 58: 1156–1162
   PubMed Web of Science ®Google Scholar
• Anderson M G, Hauer D, Sharma D P, Joag S V, Narayan O, Zink M C, Clements J E. Analysis of envelope changes acquired by SIVmac239 during neuroadaption in rhesus macaques. Virology 1993; 195: 616–626
   Google Scholar
• Arvin K L, Han B H, Du Y, Lin S Z, Paul S M, Holtzman D M. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 2002; 52: 54–61
   PubMed Web of Science ®Google Scholar
• Babas T, Dewitt J B, Mankowski J L, Tarwater P M, Clements J E, Zink M C. Progressive selection for neurovirulent genotypes in the brain of SIV-infected macaques. AIDS 2006; 20: 197–205
   Google Scholar
• Barber S A, Gama L, Dudaronek J M, Voelker T, Tarwater P M, Clements J E. Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model. J Infect Dis 2006; 193: 963–970
   Google Scholar
• Barber S A, Herbst D S, Bullock B T, Gama L, Clements J E. Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J Neuro Virol 2004; 10(Suppl 1)15–20
   Google Scholar
• Chen M, Ona V O, Li M, Ferrante R J, Fink K B, Zhu S, Bian J, Guo L, Farrell L A, Hersch S M, Hobbs W, Vonsattel J P, Cha J H, Friedlander R M. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 2000; 6: 797–801
   PubMed Web of Science ®Google Scholar
• Chen Z, Kwon D, Jin Z, Monard S, Telfer P, Jones M S, Lu C Y, Aguilar R F, Ho D D, Marx P A. Natural infection of a homozygous delta24 CCR5 red-capped mangabey with an R2b-tropic simian immunodeficiency virus. J Exp Med 1998; 188: 2057–2065
   PubMedGoogle Scholar
• Clements J E, Babas T, Mankowski J L, Suryanarayana K, Piatak M, Jr, Tarwater P M, Lifson J D, Zink M C. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 2002; 186: 905–913
   PubMed Web of Science ®Google Scholar
• Czub S, Muller J G, Czub M, Muller-Hermelink H K. Nature and sequence of simian immunodeficiency virus-induced central nervous system lesions: a kinetic study. Acta Neuropathol 1996; 92: 487–498
   Google Scholar
• Davis L E, Hjelle B L, Miller V E, Palmer D L, Llewellyn A L, Merlin T L, Young S A, Mills R G, Wachsman W, Wiley C A. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992; 42: 1736–1739
   PubMed Web of Science ®Google Scholar
• Du Y, Ma Z, Lin S, Dodel R C, Gao F, Bales K R, Triarhou L C, Chernet E, Perry K W, Nelson D L, Luecke S, Phebus L A, Bymaster F P, Paul S M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A 2001; 98: 14669–14674
   PubMed Web of Science ®Google Scholar
• Dudaronek J M, Barber S A, Clements J E. CUGBP1 is required for IFNbeta-mediated induction of dominant-negative CEBPbeta and suppression of SIV replication in macrophages. J Immunol 2007; 179: 7262–7269
   Google Scholar
• Edinger A L, Amedee A, Miller K, Doranz B J, Endres M, Sharron M, Samson M, Lu Z-H, Clements J E, Murphy-Corb M, Peiper S C, Parmentier M, Broder C C, Doms R W. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc Natl Acad Sci U S A 1997a; 94: 4005–4010
   PubMed Web of Science ®Google Scholar
• Edinger A L, Mankowski J L, Doranz B J, Margulies B J, Lee B, Rucker J, Sharron M, Hoffman T L, Berson J F, Zink M C, Hirsch V M, Clements J E, Doms R W. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci USA 1997b; 94: 14742–14747
   PubMed Web of Science ®Google Scholar
• Ellis R (2007) ISNV Meeting, San Diego, CA, November, 2007
   Google Scholar
• Flaherty M T, Hauer D A, Mankowski J L, Zink M C, Clements J E. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol 1997; 71: 5790–5798
   PubMed Web of Science ®Google Scholar
• Gibbs A, Andrewes D G, Szmukler G, Mulhall B, Bowden S C. Early HIV-related neuropsychological impairment: relationship to stage of viral infection. J Clin Exp Neuropsychol 1990; 12: 766–780
   PubMed Web of Science ®Google Scholar
• Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D, Adle-Biassette H, Wingertsmann L, Durigon M, Hurtrel B, Chiodi F, Bell J, Lantos P. Neuropathology of early HIV-1 infection. Brain Pathol 1996; 6: 1–15
   PubMed Web of Science ®Google Scholar
• Griffin D E. Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol 2003; 3: 493–502
   PubMed Web of Science ®Google Scholar
• Guillemin G, Croitoru J, Le Grand R L, Franck-Duchenne M, Dormont D, Boussin F D. Simian immunodeficiency virus mac251 infection of astrocytes. J Neuro Virol 2000; 6: 173–186
   Web of Science ®Google Scholar
• Helke K L, Queen S E, Tarwater P M, Turchan-Cholewo J, Nath A, Zink M C, Irani D N, Mankowski J L. 14–3–3 protein in CSF: an early predictor of SIV CNS disease. J Neuropathol Exp Neurol 2005; 64: 202–208
   Google Scholar
• Honda Y, Rogers L, Nakata K, Zhao B Y, Pine R, Nakai Y, Kurosu K, Rom W N, Weiden M. Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 1998; 188: 1255–1265
   Google Scholar
• Keswani S C, Jack C, Zhou C, Hoke A. Establishment of a rodent model of HIV-associated sensory neuropathy. J Neurosci 2006; 26: 10299–10304
   Google Scholar
• Kornbluth R S, Oh P S, Munis J R, Cleveland P H, Richman D D. The role of interferons in the control of HIV replication in macrophages. Clin Immunol Immunopathol 1990; 54: 200–219
   Google Scholar
• Laast V A, Pardo C A, Tarwater P M, Queen S E, Reinhart T A, Ghosh M, Adams R J, Zink M C, Mankowski J L. Pathogenesis of simian immunodeficiency virus-induced alterations in macaque trigeminal ganglia. J Neuropathol Exp Neurol 2007; 66: 26–34
   Google Scholar
• Lane J H, Sasseville V G, Smith M O, Vogel P, Pauley D R, Heyes M P, Lackner A A. Neuroinvasion by simian immunodeficiency virus coincides with increased numbers of perivascular macrophages/ microglia and intrathecal immune activation. J Neuro Virol 1996a; 2: 423–432
   PubMed Web of Science ®Google Scholar
• Lane J H, Tarantal A F, Pauley D, Marthas M, Miller C J, Lackner A A. Localization of simian immunodeficiency virus nucleic acid and antigen in brains of fetal macaques inoculated in utero. Am J Pathol 1996b; 149: 1097–1104
   Google Scholar
• Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier A C, Gelman B B, McArthur J C, McCutchan J A, Morgello S, Simpson D, Grant I, Ellis R J. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008; 65: 65–70
   PubMed Web of Science ®Google Scholar
• Mankowski J L, Flaherty M T, Spelman J P, Hauer D A, Didier P J, Amedee A M, Murphey-Corb M, Kirstein L M, Munoz A, Clements J E, Zink M C. Pathogenesis of simian immunodeficiency virus encephalitis: viral determinants of neurovirulence. J Virol 1997; 71: 6055–6060
   PubMed Web of Science ®Google Scholar
• Mankowski J L, Queen S E, Clements J E, Zink M C. Cerebrospinal fluid markers that predict SIV CNS disease. J Neuroimmunol 2004; 157: 66–70
   Google Scholar
• Mankowski J L, Queen S E, Tarwater P M, Fox K J, Perry V H. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 2002; 61: 85–90
   PubMedGoogle Scholar
• Marx P A, Chen Z. The function of simian chemokine receptors in the replication of SIV. Semin Immunol 1998; 10: 215–223
   Google Scholar
• Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 2000; 69: 376–380
   PubMed Web of Science ®Google Scholar
• McArthur J C, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N. Human immunodeficiency virus-associated dementia: an evolving disease. J Neuro Virol 2003; 9: 205–221
   PubMed Web of Science ®Google Scholar
• Metz L M, Zhang Y, Yeung M, Patry D G, Bell R B, Stoian C A, Yong V W, Patten S B, Duquette P, Antel J P, Mitchell J R. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2004; 55: 756–758
   PubMed Web of Science ®Google Scholar
• O'Dell J R, Blakely K W, Mallek J A, Eckhoff P J, Leff R D, Wees S J, Sems K M, Fernandez A M, Palmer W R, Klassen L W, Paulsen G A, Haire C E, Moore G F. Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum 2001; 44: 2235–2241
   PubMedGoogle Scholar
• Overholser E D, Coleman G D, Bennett J L, Casaday R J, Zink M C, Barber S A, Clements J E. Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro. J Virol 2003; 77: 6855–6866
   Google Scholar
• Pettersen J A, Jones G, Worthington C, Krentz H B, Keppler O T, Hoke A, Gill M J, Power C. Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity. Ann Neurol 2006; 59: 816–824
   PubMed Web of Science ®Google Scholar
• Popovic N, Schubart A, Goetz B D, Zhang S C, Linington C, Duncan I D. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 2002; 51: 215–223
   PubMed Web of Science ®Google Scholar
• Sacktor N, McDermott M P, Marder K, Schifitto G, Selnes O A, McArthur J C, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida J A, Cohen B, Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neuro Virol 2002; 8: 136–142
   PubMed Web of Science ®Google Scholar
• Saito Y, Sharer L R, Epstein L G, Michaels J, Mintz M, Louder M, Golding K, Cvetkovich T A, Blumberg B M. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994; 44: 474–481
   PubMed Web of Science ®Google Scholar
• Simpson D M, Kitch D, Evans S R, McArthur J C, Asmuth D M, Cohen B, Goodkin K, Gerschenson M, So Y, Marra C M, Diaz-Arrastia R, Shriver S, Millar L, Clifford D B. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 2006; 66: 1679–1687
   PubMed Web of Science ®Google Scholar
• Smyth K, Affandi J S, McArthur J C, Bowtell-Harris C, Mijch A M, Watson K, Costello K, Woolley I J, Price P, Wesselingh S L, Cherry C L. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med 2007; 8: 367–373
   PubMed Web of Science ®Google Scholar
• Thomas M, Le W D, Jankovic J. Minocycline and other tetracycline derivatives: a neuroprotective strategy in Parkinson's disease and Huntington's disease. Clin Neuropharmacol 2003; 26: 18–23
   Google Scholar
• Tornatore C, Chandra R, Berger J R, Major E O. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994; 44: 481–487
   PubMed Web of Science ®Google Scholar
• Trichel A M, Rajakumar P A, Murphey-Corb M. Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J Med Primatol 2002; 31: 171–178
   PubMed Web of Science ®Google Scholar
• Weed M R, Hienz R D, Br-ady J V, Adams R J, Mankowski J L, Clements J E, Zink M C. Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection. J Neuro Virol 2003; 9: 452–464
   Google Scholar
• Wynn H E, Brundage R C, Fletcher C V. Clinical implications of CNS penetration of antiretroviral drugs. CNS Drugs 2002; 16: 595–609
   PubMed Web of Science ®Google Scholar
• Zhu S, Stavrovskaya I G, Drozda M, Kim B Y, Ona V, Li M, Sarang S, Liu A S, Hartley D M, Wu du C, Gullans S, Ferrante R J, Przedborski S, Kristal B S, Friedlander R M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 2002; 417: 74–78
   PubMed Web of Science ®Google Scholar
• Zink M C, Amedee A M, Mankowski J L, Craig L, Didier P, Carter D L, Munoz A, Murphey-Corb M, Clements J E. Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV. Am J Pathol 1997; 151: 793–803
   Google Scholar
• Zink M C, Clements J E. A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease. J Neuro Virol 2002; 8(Suppl 2)42–48
   PubMed Web of Science ®Google Scholar
• Zink M C, Coleman G D, Mankowski J L, Adams R J, Tarwater P M, Fox K, Clements J E. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 2001; 184: 1015–1021
   PubMed Web of Science ®Google Scholar
• Zink M C, Suryanarayana K, Mankowski J L, Shen A, Piatak M, Jr., Spelman J P, Carter D L, Adams R J, Lifson J D, Clements J E. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999; 73: 10480–10488
   PubMed Web of Science ®Google Scholar
• Zink M C, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J, Tarwater P, Clements J, Barber S. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 2005; 293: 2003–2011
   PubMed Web of Science ®Google Scholar